New FDA Pulse Oximetry Guidance: Strengths and Weaknesses
Update: 2025-03-05
Description
The US Food and Drug Administration (FDA) issued new draft regulatory guidance for pulse oximeters related to skin pigment. The guidance is a step forward but it may have unintended consequences. Authors Michael Lipnick, MD, and Philip Bicker, MD, PhD, professors of anesthesia at University of California, San Francisco, discuss this and more with JAMA Executive Editor Gregory Curfman, MD.
Related Content:
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
